Wstęp: Ostra niewydolność nerek jest rzadkim (2-15%), ale bardzo niebezpiecznym powikłaniem operacji kardiochirurgicznych, obarczonym śmiertelnością rzędu 40-80%. W celu ratowania życia chorzy poddawani są zabiegom dializoterapii. Celem pracy była ocena wpływu określonych czynników na śmiertelność wśród pacjentów kardiochirurgicznych poddanych terapii nerkozastępczej z powodu ostrej pooperacyjnej niewydolności nerek. Materiał i metody: Retrospektywnej analizie poddano dane 45 pacjentów operowanych kardiochirurgicznie w latach 2009-2013, u których włączono terapię nerkozastępczą z powodu pooperacyjnej ostrej niewydolności nerek. Analizowano związek czynników okołooperacyjnych ze śmiertelnością, dzieląc przy tym pacjentów na grupę nr 1 -zmarłych w trakcie leczenia; oraz grupę nr 2 -tych, którzy przeżyli do momentu wypisania ze szpitala. Wyniki: Spośród 3509 pacjentów 45 (1,25%) wymagało włą-czenia leczenia nerkozastępczego po operacji. Przed wypisem ze szpitala zmarły 23 osoby (51,11%) (grupa nr 1). Pacjentów z tej grupy charakteryzował starszy średni wiek (70,21 vs 67 lat) i wyższy średni wynik w skali EuroSCORE (9,28 vs 7,15) (p < 0,05), częściej przechodzili zabieg złożony (63,63% vs 28,57%) (p < 0,05), częściej wymagali podawania katecholamin w okresie pooperacyjnym (100% vs 68,42%) (p < 0,005) oraz mieli większe średnie stężenie mocznika we krwi przed rozpoczęciem dializ (156,65 vs 102,54 mg/dl) (p < 0,05). Wnioski: Wysoki wynik w skali EuroSCORE, zabieg złożony, duże stężenie mocznika we krwi przy włączaniu terapii nerkozastęp-czej oraz potrzeba użycia katecholamin w okresie pooperacyjnym okazały się statystycznie istotnymi czynnikami zwiększa-jącymi śmiertelność w badanej populacji chorych. Wymienione czynniki mogą posłużyć do identyfikacji pacjentów o zwiększo-nym ryzyku zgonu, wymaga to jednak potwierdzenia w dalszych badaniach na szerszej populacji chorych. Słowa kluczowe: terapia nerkozastępcza, ostra niewydolność nerek.
Introduction
Acute renal failure (ARF) requiring the use of renal replacement therapy (RRT) is a rare, but very severe complication of cardiac surgery. It is a sudden renal insufficiency accompanied by higher creatinine blood level and oliguria, defined as urine output < 0.5 ml/kg per hour. Its incidence varies from 2% to 15% with overall mortality as high as 40% to 80%, highlighting the importance of this issue [1, 2] . Moreover, ARF has been proven to be an independent predictor of death after cardiac surgery [3] . One of the main problems faced by physicians in everyday practice is a lack of consensus on the diagnostic criteria for ARF and the optimal time to initiate RRT. In this study ARF was considered in the case of oliguria or if there was a clinical need for RRT initiation (e.g. uncontrollable hyperkalaemia).
The aim of our study was to find differences between two observed groups of patients, who underwent dialysis as a treatment for ARF after cardiac surgery: those who died during treatment (group 1) and those who survived until hospital discharge (group 2). Modifiable and unmodifiable factors connected with heart operation were analysed in order to find predictors of mortality in the examined population.
Material and methods
The retrospective analysis included 45 patients diagnosed with ARF after cardiac surgery and subsequently treated with RRT in our clinic in years 2009 to 2013. Data was obtained from patients' records as well as the hospital's cardiac surgery database.
Collected information was divided into three categories: I. Preoperative factors: patient's sex, age, weight, height, body mass index (BMI), ejection fraction (EF), EuroSCORE value, creatinine blood level, estimated glomerular filtration rate (eGFR) on admission, recent myocardial infarction (≤ 90 days before surgery) or angiography procedure (≤ 14 days before surgery), history of diabetes, hypertension, and heart failure. II. Factors associated with the surgery: procedure other than coronary artery bypass graft surgery (CABG), reoperation, concomitant surgery (e.g. CABG plus aortic valve replacement), use of extracorporeal circulation (ECC), time of ECC, time of cross clamp, and use of catecholamines and intra-aortic balloon pump (IABP) during surgery. III. Postoperative factors: respiratory support (> 4 days after surgery), drainage (> 1000 ml/24 h), day of RRT initiation, creatinine, urea and potassium blood levels at RRT initiation, bacteremia and maximal C-reactive protein (CRP) level, and administration of catecholamines and IABP in the postoperative period. Statistical analysis was performed by Stat-Soft, Inc. STA-TISTICA (data analysis software system) version 12.0, using χ 2 test, t-test, and U Mann-Whitney test.
Results
In total 1.25% of patients treated in our clinic in years 2009-2013 (45 out of 3590 patients) developed ARF requiring RRT after cardiac surgery. Twenty-three (51.11%) died before discharge. As shown in Table I , patients who died during treatment (group 1) were older and had higher mean BMI value than those who survived until discharge. Before the operation patients in group 1 had lower mean ejection fraction (EF) value; in this group we also observed higher percentage of patients diagnosed with heart failure, hypertension, or recent (≤ 90 days before surgery) myocardial infarction and higher percentage of angiography procedures (≤ 14 days before surgery). Surprisingly, patients in group 1 showed lower mean creatinine blood level values. However, none of those findings proved to be of statistical significance. After the statistical analysis the only significant preoperative death risk factor proved to be high score on the EuroSCORE scale, with a mean value of 9.28 in group 1 (survivors) vs. 7.15 in group 2 (p < 0.05).
When it comes to factors associated with the surgery, only the higher percentage of concomitant cardiac surgeries (e.g. CABG and concomitant aortic valve replacement) in group 1 (63.63% vs. 28.57%) turned out to be a statistically significant death predictor (p < 0.05). Patients in group 1 were more often reoperated, had procedure other than CABG, and a higher percentage of surgeries in extracorporeal circulation (ECC). In this group the time of ECC and the cross clamp time were also longer. Administration of catecholamines and use of IABP during the operation were less frequent in group 1.
In the category of postoperative factors, admission of catecholamines (postop.) (100% vs. 68.42%) (p < 0.005) and higher blood urea values at RRT initiation (156.65 mg/dl vs. 102.54 mg/dl) (p < 0.05) proved to be statistically significant death predictors. A higher percentage of patients in group 1 required administration of catecholamines (postop.), IABP (postop.), respiratory support (> 4 days), and drainage > 1000 ml/24 h. They showed higher incidence of bacteraemia and higher maximal CRP levels. Surprisingly, in group 1, RRT was started earlier (4.5 vs. 5.47 day) with lower mean blood levels of urea, creatinine, and potassium prior to its initiation (Table I) .
Discussion
Although there are many studies that have focused on the problem of ARF after cardiac surgery, there is still no consensus on a clear definition or precise pathophysiological mechanisms, risk factors, and practical guidelines concerning ARF patients, which in turn leads to poor outcomes.
Prerenal acute kidney insufficiency is caused by a decline in renal blood flow. It is not connected with disturbance of kidneys themselves, as in the case of renal ARF. Hypoperfusion of renal medulla, caused by vasoconstriction of renal arterioles and redistribution of blood flow within kidneys, seems to be the most likely mechanism leading to postoperative ARF. Therefore, if rapid and effective treatment reinforcing renal blood flow is undertaken the filtration will increase as well as the urine output. That is why fast diagnosis and treatment is of utmost importance to avoid ARF [4] [5] [6] . Multi-factor analysis of failure of renal replacement therapy in acute renal failure developed after cardiac surgery Nowadays, patients with acute kidney injury are often ordinated with RRT only after significant disturbance of acid-alkaline balance. The tendency is to delay the process of dialysis as long as the imbalance does not occur in order to avoid side effects of RRT. The presentation of AKI is connected with individual predisposition [7] .
There is a high number of risk factors mentioned in literature, suggested to provoke ARF after heart surgery, including: age [8] , diabetes [9] [10] [11] [12] , previous cardiovascular surgery [4] , CPB time [13] , duration of cross-clamp time [14] , generalised inflammatory response as a consequence of the CPB circuit [15] , and exposure to iodine dye (coronarography) a short time before surgery [16] . However, analysis of those variables did not change any statistically important differences between group 1 and 2.
On the other hand, EuroSCORE or the need of vasopressor support after surgery [17] proved to be statistically meaningful mortality predictors in the group of patients treated with RRT. However, those factors are generally associated with higher death risk in all patients undergoing surgery, not peculiarly those diagnosed with ARF.
Surprisingly, there was a relevant difference in urea level at RRT initiation without a significant discrepancy in creatinine level. Therefore, level of urea should not be underestimated or omitted when creatinine level is within normal limits. Also, the fact of undergoing a concomitant surgery turned out to be a statistically important factor affecting the patients' mortality rate. However, parameters such as CPB use, CPB time, or cross clamp time did not prove to be of statistical significance.
Limitations
A relatively small group of patients and lack of followup observation after discharge (only short-term results) may have been limitations of our study.
Conclusions
Statistically significant death predictors in the group of patients treated with RRT because of acute kidney insufficiency that occurred after cardiac surgery turned out to be: high EuroSCORE, concomitant surgery, high urea level at RRT initiation, and admission of catecholamines in the postoperative period. The presented observations should be further investigated on a larger group of patients, followed by the creation of practical guidelines on the treatment of postoperative ARF and the place of renal replacement therapy within that process.
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